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In this chapter, an attempt is made to discuss the clinical and commercial 
value of our findings and how they can be translated into the clinic in the field 
of tissue engineering and regenerative medicine. The final goal of our 
scientific output is to transfer the research findings into practice, via which they 
can contribute to clinical and commercial application. The application to 
generate value in this process is called “valorisation”. The development of 
tissue engineering scaffolds are likely to bring clinical and commercial benefits 
to the society. Our study on fabrication of self-assembled honeycomb 
scaffolds to induce angiogenesis in Chapter 4 showed high potential for 
valorisation.  
Clinical and commercial relevance 
The biomedical research has risen rapidly because people could benefit from 
it. The life expectancy of young generation is increasing and the chronic 
disability of old people is decreasing, these trends is mainly due to the fast 
development of biomedical technologies [1]. Our society emphasizes the 
importance of biomedical development and has spent lots of money in 
biomedical research. For example, the estimated yearly cost of 
pharmaceutical, biotechnology, and medical companies on biomedical 
research is more than $60 billion worldwide [2]. Despite some biomedical 
products have shown initial successes in translating from the lab to the clinic, 
the ability to regenerate complex tissue/organ is still one of the great 
challenges for clinical use [3]. In tissue engineering, cells from patients are 
seeded into an appropriate 3D scaffold to generate the tissue construct. 
However, the lack of adequate and fast vascularization often lead to cell death 
after seeding [4]. The formation of new tissue constructs needs blood vessels 
to continuously supply oxygen and nutrition [5]. Insufficient blood supply limits 
the size of tissue-engineered constructs and results in failure of translation [6]. 
In order to solve this problem, we developed a self-assembled honeycomb 
scaffold that could afford biophysical cues to induce initial blood vessel 
formation.  
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Honeycomb nanofibrous scaffolds created by the self-assembly of 
electrospun fibers could mimic the capillary network of endothelial cells 
(Figure 1). Some studies reported that the honeycomb-like network of 
endothelial cells is a very important morphogenetic feature that could simulate 
tube formation during angiogenesis [7, 8]. The wall of honeycomb scaffolds 
contains connected fiber clusters and beads, therefore allowing cells to 
adhere on the wall and possibly guide cell migration. In chapter 4, we showed 
that the fabricated honeycomb scaffolds significantly promoted HUVECs 
proliferation and influenced the distribution of cells. Especially, honeycomb 
electrospun scaffolds could regulate HUVECs morphogenesis into capillary-
like structures with a central lumen.  
 
Figure 1. SEM images of honeycomb (a) PCL electrospun nanofibers. Images (c and d) showed 
the tube formation of HUVECs cultured on Matrigel-coated wellplate after 16 h. Scale bars are 
500μm (a) and 100μm (b, c and d).  
 
Target group 
Our findings on the development of honeycomb nanofibrous scaffolds for 
vascular tissue engineering can benefit other researchers. For example, many 
studies reported how geometrical cues affect endothelial cell tube formation 
by using micropatterned stripes. To the best of our knowledge, no study was 
performed so far on the influence of honeycomb patterns on tube formation. 
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Here, we focused on the effect of honeycomb patterns on vessel formation. 
Investigating the effect of honeycomb pattern on angiogenesis will pave the 
way towards the fabrication of advanced angiogenic scaffolds that hold to be 
more promising for clinical applications. Beyond the preliminary studies that 
we have here reported, the efficacy and safety of honeycomb scaffolds have 
to be tested by further in vitro and in vivo assays, before finally being 
translated in patients [9]. After getting approval for clinical trials, the final 
products could attract the attention of investors, making it possible to enter 
into the market.  
Innovation and implementation 
Chapter 4 investigated the positive role of honeycomb patterns in promoting 
angiogenesis. The novelty of this study is 1) using a self-assembled 
electrospinning approach to fabricate a honeycomb pattern, and 2) guiding 
endothelial cells morphogenesis into capillary network through the 
honeycomb scaffolds, finally promoting tube formation. This honeycomb 
scaffold in principle could be used for some applications where 
prevascularization is highly needed to rapidly generate vascular network 
before implantation. Serval studies have reported the addition of endothelial 
cells sheets for vascularized bone regeneration [10, 11]. During 
prevascularization, human mesenchymal stromal cells (hMSCs) are seeded 
on honeycomb scaffolds and human umbilical vein endothelial cells (HUVECs) 
are seeded on the top of hMSCs in order to generate vascularized tissue 
constructs. The geometric cues of honeycomb scaffolds could accelerate the 
initial vascular network formation. This could shorten the time during which 
tissue construct suffers from hypoxia and lack of nutrition.  
The honeycomb scaffolds are made from poly(caprolactone), which has been 
approved by Food and Drug Administration (FDA) and already used in 
patients as drug delivery devices and sutures. Furthermore, to fabricate 
thermal-triggered cells sheets, honeycomb patterns could be produced from 
electrospinning of thermosresponsive polymers (e.g. pNIPAAm). After using 
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such honeycomb thermal scaffolds, cultured endothelial layers or mixtures of 
endothelial cells with other cell types could be easily harvested by changing 
temperature. This improvement could be more promising for tissue 
implantation.  
Our findings has only been proved by in vitro studies, so that the application 
of honeycomb scaffolds in vivo should be further investigated. The next step 
is to perform animal tests to confirm the efficacy and safety of honeycomb 
scaffolds on angiogenesis. If our results were confirmed in larger animal tests, 
these honeycomb scaffolds would then be eligible for further clinical 
experimentation, after having passed regulatory and medical ethical approval. 
Clinical testing without significant side effects or safety issues would provide 
these scaffolds a chance to secure further investment for introduction into the 
market. Another potential value of our findings is that researchers may also 
consider the role of geometric cues when designing biomaterials for vascular 
regeneration. Especially, highly vascularized tissues may require the fast 
formation of blood vessels to support regeneration. 
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